Skip to main content
MNRO
NASDAQ Trade & Services

Monro Details Poor Performance, Activist Defense, and Dual-Class Share Elimination

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Automotive Stocks · Consumer
Sentiment info
Negative
Importance info
8
Price
$17.24
Mkt Cap
$514.933M
52W Low
$12.255
52W High
$23.91
52W Position info
41% above low
Off High info
28% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

MNRO sits 41% above its 52-week low of $12.255.

Summary

Monro's proxy statement highlights weak Fiscal 2026 performance, leading to low executive bonuses and worthless equity awards, alongside defensive measures against activist investor Icahn and a positive elimination of its dual-class share structure.


Key Events · Corporate Governance and Compliance · MNRO

  • Poor Fiscal 2026 Performance

    Adjusted Operating Income achieved 52.7% of target, and Comparable Store Sales achieved 0% of target, significantly impacting executive cash bonuses.

  • CEO Equity Awards Underperforming

    A substantial portion of the CEO's performance-based equity (PSUs) is currently worthless, requiring the stock price to reach $25.00 for any payout, compared to the current $17.24.

  • Shareholder Rights Plan (Poison Pill)

    The Board approved a limited-duration poison pill in November 2025 in response to Icahn Enterprises L.P. accumulating a 33.4% economic exposure, signaling a defensive posture against potential control changes.

  • Dual-Class Share Structure Eliminated

    The company converted 19,664 shares of Class C Preferred Stock into 1,204,908 shares of common stock on June 18, 2026, simplifying the capital structure and enhancing common shareholder voting rights.


Analysis · MNRO · Trade & Services

The definitive proxy statement reveals significant underperformance in Fiscal 2026, with executive bonuses severely impacted by missed operating income and comparable store sales targets. The CEO's performance-based equity awards are largely worthless due to the stock trading below the vesting threshold. The company also implemented a shareholder rights plan (poison pill) in response to activist investor Icahn Enterprises accumulating a substantial economic stake, indicating potential control contest. Positively, the company eliminated its dual-class share structure, converting preferred shares into common stock, which enhances common shareholder rights.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MNRO was trading at $17.24 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $514.9M. The 52-week trading range was $12.26 to $23.91. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MNRO - Latest Insights

MNRO
Nov 04, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.11
Real-time Price: $9.29 info
Change: -$2.82 (-23%) info
Market Cap: $291.34M info
MNRO
Oct 29, 2026, 11:44 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $12.47
Real-time Price: $9.29 info
Change: -$3.18 (-25%) info
Market Cap: $291.34M info
MNRO
Oct 29, 2026, 7:58 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.00
Real-time Price: $9.29 info
Change: -$3.71 (-29%) info
Market Cap: $291.34M info
MNRO
Oct 29, 2026, 7:35 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.30
Real-time Price: $9.29 info
Change: -$5.01 (-35%) info
Market Cap: $291.34M info
MNRO
Oct 29, 2026, 7:30 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $14.30
Real-time Price: $9.29 info
Change: -$5.01 (-35%) info
Market Cap: $291.34M info